Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Using sun protection is a year-round, no exceptions recommendation.
Pembrolizumab led to 56 percent overall response rate for rare skin cancer.
Here are the cancer treatment news stories with the most views this year.
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
How a new technology solved a mystery and honors one man’s legacy
“The challenge now is to exploit this knowledge for therapeutics,” says researcher Joaquin Espinosa, PhD.
Cemiplimab is the first treatment for metastatic or locally advanced cutaneous squamous cell carcinoma.
In every issue of Cancer Health, you’ll find cutting-edge health information and the hottest topics of interest to people with cancer and th...
The social media campaign raises awareness of the fact that the sun is just as dangerous in the winter as it is in the summer.
Don’t forget the sunscreen on those last days at the beach.
Research on severe inherited childhood skin disorder reveals how tissue injury can lead to cancer.
Efficacy of novel approach in human lung, skin, colon, pancreatic cancers in lab experiments prompts rapid move toward clinical trial.
Your questions answered
Innovative CRISPR study recreates genetic steps required for benign moles to turn malignant
Caitlyn Jenner is raising awareness of skin cancer after unveiling her diagnosis earlier this year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.